Clinical Trials in North Carolina

Showing 9941-9960 of 15,496 trials

Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects

NCT01145066

This study will compare how well a combination of borage and echium oils will reduce inflammation compared to fish oils and placebo oil in subjects that are diabetic or have metabolic syndrome.

DiabetesMetabolic Syndrome x

Wake Forest University Health Sciences80 participantsStarted May 2009

Winston-Salem, North Carolina, United States

COMPLETEDPhase 341 miles

Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies

NCT00135902

A recently completed trial of weekly injections of 17 alpha hydroxyprogesterone caproate (17P) found significant effectiveness for 17P in preventing recurrent preterm birth. However, the group who received 17P in this trial still had a high rate of preterm birth. Several reports have shown that dietary supplementation of fish oil, which is rich in Omega-3 fatty acids, reduces the risk of preterm birth. This trial tests whether adding the Omega-3 supplement to 17P therapy has the potential for further reducing the risk of preterm birth in women who have previously had a spontaneous preterm delivery. The trial will compare Omega-3 fatty acid with placebo in women receiving 17P therapy. The hypothesis being tested is: "Among women at high risk for preterm birth receiving weekly injections of 17P, the addition of Omega-3 nutritional supplement will further reduce the rate of preterm birth."

Preterm Birth

The George Washington University Biostatistics Center800 participantsStarted Feb 2005

Birmingham, Alabama, United States • Chicago, Illinois, United States • Detroit, Michigan, United States +9 more locations

Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects

Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies

Find Trials by Condition in North Carolina

Solace Stress Urinary inContinence Control Efficacy and Safety Study

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Fetal ST Segment and T Wave Analysis in Labor

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung

Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

Assessment of Effect of Rapastinel on Driving Performance

Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)